Yota Sato
Overview
Explore the profile of Yota Sato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawaguchi C, Ozawa M, Hidaka T, Murakami K, Ishikuro M, Ueno F, et al.
Allergol Int
. 2024 Oct;
PMID: 39426877
Background: Precise skin phenotypic data are indispensable in accurately diagnosing atopic dermatitis (AD). Therefore, this study examined the interobserver concordance for AD and non-AD diagnoses between two dermatologists. AD prevalence...
2.
Sato Y, Kamei A, Endo F, Matsuyama S, Toda H, Kasai T
Nutrients
. 2024 Jan;
16(1).
PMID: 38201951
Vitamin D (VD) deficiency can lead to health-related consequences. This study determined the effects of VD administration in VD-deficient children with severe motor and intellectual disabilities (SMID). Twenty-eight subjects were...
3.
Sato Y, Kamei A, Toda H, Endo F, Kasai T
J Bone Miner Metab
. 2022 Nov;
41(1):52-60.
PMID: 36357744
Introduction: Nutritional prevention of osteoporosis management is an important issue for children with severe disabilities. Due to the coronavirus disease 2019 (COVID-19) pandemic that started in 2020, children admitted to...
4.
Segawa Y, Tono H, Chiba H, Sato Y, Asano Y
J Dermatol
. 2022 Aug;
49(12):1330-1333.
PMID: 35962474
Local skin flap from the surrounding area is often chosen for reconstruction of skin defects in the nasal region, but it is problematic because it creates new facial scar and...
5.
Funato T, Sato Y, Sato Y, Fujiki S, Aoi S, Tsuchiya K, et al.
Sci Rep
. 2021 Oct;
11(1):20362.
PMID: 34645901
Impairment of inferior olivary neurons (IONs) affects whole-body movements and results in abnormal gait and posture. Because IONs are activated by unpredicted motion rather than regular body movements, the postural...
6.
Sato Y, Fujimura T, Hidaka T, Lyu C, Tanita K, Matsushita S, et al.
Front Immunol
. 2020 Nov;
11:534323.
PMID: 33178182
Aryl hydrocarbon receptor (AhR) provides a deeper insight into the pathogenesis of cutaneous squamous cell carcinoma (cSCC). AhR ligands, such as 6-formylindolo[3,2-b] carbazole (FICZ), and 7,12-Dimethylbenz[a]anthracene (DMBA), constitute major substrates...
7.
Fujimura T, Tanita K, Ohuchi K, Sato Y, Lyu C, Kambayashi Y, et al.
Melanoma Res
. 2020 Jul;
30(6):613-618.
PMID: 32658051
Nivolumab plus ipilimumab combined therapy is among the most effective therapies for advanced melanoma. However, this therapy is also associated with a high frequency of immune-related adverse events (irAEs). To...
8.
Lyu C, Fujimura T, Amagai R, Ohuchi K, Sato Y, Tanita K, et al.
J Dermatol Sci
. 2020 Jul;
99(1):65-68.
PMID: 32605834
No abstract available.
9.
Ohuchi K, Fujimura T, Kambayashi Y, Amagai R, Lyu C, Tanita K, et al.
Dermatol Ther
. 2020 May;
33(4):e13487.
PMID: 32362053
Mogamulizumab shows cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity (ADCC) in advanced cutaneous T-cell lymphoma (CTCL) patients. Although mogamulizumab is used as one of the anchor drugs for...
10.
Fujimura T, Kambayashi Y, Ohuchi K, Amagai R, Sato Y, Tanita K, et al.
Case Rep Oncol
. 2020 Apr;
13(1):271-275.
PMID: 32308589
Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy...